NCT00871910 Phase 1 Every-3-Week Dosing of SCH 727965 in Patients With Advanced Cancer (Study P04630) Status COMPLETED Phase PHASE1
NCT00871871 Multiple Dose Effects of Hydrochlorothiazide and Isosorbide Mononitrate on Glucose Homeostasis (MK-0000-117)(Completed) Status COMPLETED Phase PHASE1
NCT00871663 Phase 1 Weekly Dosing of SCH 727965 in Patients With Advanced Cancer (Study P04629AM6) Status COMPLETED Phase PHASE1
NCT00871546 SCH 727965 in Patients With Mantle Cell Lymphoma or B-Cell Chronic Lymphocytic Leukemia (Study P04715) Status TERMINATED Phase PHASE2
NCT00868790 A Study of the Safety and Efficacy of MK-3577 in Participants With Type 2 Diabetes Mellitus (MK-3577-009) Status TERMINATED Phase PHASE2
NCT00868556 fMRI of the Brainstem in Migraine Sufferers and Controls. Does Iron Deposition Correlate With Progression of Disease? Status COMPLETED Phase N/A
NCT00867165 Pediatric Study to Evaluate the Efficacy and Safety of Ezetimibe Monotherapy in Children With Primary Hypercholesterolemia (P05522) Status COMPLETED Phase PHASE3
NCT00863590 A Single-Dose Study of the Safety, Tolerability, and Pharmacokinetics of Odanacatib (MK0822) in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT00863525 A Study to Assess the Effects of a Light Breakfast on the Safety, Tolerability, and Pharmacokinetics of Odanacatib (MK0822) Status COMPLETED Phase PHASE1
NCT00863109 Quality of Life During Treatment of Chronic Hepatitis C (P05278/MK-4031-336) Status COMPLETED Phase N/A
NCT00861406 Adjuvant Therapy of Pegylated Interferon- 2b Plus Melanoma Peptide Vaccine Status COMPLETED Phase PHASE1
NCT00860587 Antibiotic Resistant Bacteria Among Patients With Severe Intraabdominal Infections Status UNKNOWN Phase N/A
NCT00860535 Growth Factor Signature (GFS) Pilot Study (MK0000-098)(COMPLETED) Status TERMINATED Phase PHASE1
NCT00860392 A Comparison of Measurements of Ketone Body Flux Versus Ketone Body Concentration as a Pharmacodynamic Marker of Hepatic Fatty Acid Oxidation (0000-110) Status COMPLETED Phase PHASE1
NCT00858234 Phase I Study of MK-0683 in Combination With Bortezomib in Participants With Multiple Myeloma (MK-0683-098) Status COMPLETED Phase PHASE1